novo nordisk semaglutide nash Nordisk's weight-loss pill wins FDA approval Obesity | Novo Nordisk U.S.

Canadian Agency for Drugs and Technologies in Health (CADTH): Semaglutide Reimbursement Review: CADTH reimbursement guidance used by provincial drug plans for semaglutide.

P, Probiotics

Clinical trials show constipation occurs in approximately 11-24% of patients taking semaglutide and 6-11% taking tirzepatide, compared to 11% in placebo groups

Escalating to 15 mg when you only need to lose 10 more pounds puts you in a position where the step-down later is steeper and more likely to cause rebound weight gain

Changes in diet, activity levels, and time zones can affect your blood sugar

Were on one hand left with so many questions, but the answers we have point to a revolution in medicine